Will Plavix be the next drug up for a genetic test? There are not many alternative drugs either that could easily replace the functionality of Plavix, it is a blood thinner. One idea would be to monitor patients with poor liver or kidney metabolization. as suggested here , a blog written...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-02-2009
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Physician, personalized medicine, DNA, Genomics, healthcare, Health IT, Cardiology, Biotech, FDA, Information Overload, Pharmacogenomics, Sequencing, FDA warnings, Plavix
This is a very good point, getting all the data organized into a fashion where it can be used and analyzed. Back a few months ago when I interviewed Patrice Milos, Vice President and Chief Scientific Officer, of Helicos BioSciences I asked the same question, and also if each interpretation would...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-22-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, DNA, Genomics, healthcare, microsoft, Health IT, Biotech, Pharmacogenomics, Helicos, Sequencing
Pfizer is wasting no time to get the calculations running and numbers rolling. To stay in the market, they are attempting to find out as much as they can about potential side effects and other perhaps adverse affects of their drugs. Better than they find up them front, as it will make for better...
If you have not read up yet on personalized medicine this is a great article that will go through the basics in layman's terms...there are 4 links below to each section...and the last area is the toughest...the challenges as it will all be work in progress for quite a while to come...so somebody...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-24-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Labs, personalized medicine, Medicine, DNA, Biotech, healthcare providers, Advocates